New strategies for early diagnosis of heart allograft rejection

Transplantation

Volumn 64, Issue 6, 1997, Pages 842-847

  Tugulea, Sorina ^a   Ciubotariu, Rodica ^a   Colovai, Adriana I ^a   Liu, Zhuoru ^a   Itescu, Silviu ^a   Schulman, Larry L ^a   Fisher, Peter E ^a   Hardy, Mark A ^a   Rose, Eric A ^a   Michler, Robert E ^a   Cortesini, Raffaello ^b   Suciu Foca, Nicole ^a  

^a Columbia University ^*  (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA DR3 ANTIGEN;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FLOW CYTOMETRY; GRAFT REJECTION; HEART GRAFT; HLA SYSTEM; HLA TYPING; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PREDICTION; PRIORITY JOURNAL; RELIABILITY;

ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030748974     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709270-00009     Document Type: Article

References (23)

1. Hosenpud JF, Novick RJ, Bennett LE, Keck BM, Fiol B, Daily PO. The registry of the international society for heart and lung transplantation: thirteenth official report. J Heart Lung Transplant 1996; 15: 655.
2. White JA, Guirandon C, Pfluglelder PW, Kostuk WJ. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation. J Heart Lung Transplant 1995; 14: 1052.
3. Billingham M. Dilemma of variety of histopathologic grading systems for acute cardiac allograft rejection by endomyocardial biopsy. J Heart Transplant 1990; 9: 77.
4. Warnecke H, Muller J, Conhert T, et al. Clinical heart transplantation without routine endomyocardial biopsy. J Heart Lung Transplant 1992; 11: 1093.
5. Valantine H, Yeoh T, Gibbsons R, et al. Sensitivity and specificity of diastolic indexes for rejection surveillance; temporal correlation with endomyocardial biopsy. J Heart Lung Transplant 1991; 10: 557.
6. Hall T, Baumgartner W, Borkin A, et al. Diagnosis of acute cardiac rejection with antimyosin monoclonal antibody, phosphorous nuclear magnetic imaging, two dimensional echocardiography and endocardial biopsy. J Heart Transplant 1986; 5: 419.
7. Wisenberg G, Pflugfelder JV, Kostuk WJ, McKenzie FN, Prato FS. Diagnostic applicability of magnetic resonance imaging in assessing human cardiac allograft rejection. Am J Cardiol 1987; 60: 130.
8. Sethi GK, Sudhakar K, Arabia FA, Rosasdo LJ, McCarthy, Copeland JG. Is it necessary to perform surveillance endomyocardial biopsies in heart transplant recipients? J Heart Transplant 1995; 14: 1047.
9. Fisher PE, Suciu-Foca N, Ho E, Michler RE, Rose EA, Mancini D. Additive value of immunologic monitoring to histologic grading of heart allograft biopsies: implications for therapy. J Heart Lung Transplant 1995; 4: 156.
10. Liu Z, Colovai AI, Tugulea S, et al. Indirect recognition of donor HLA- DR peptides in organ allograft rejection. J Clin Invest 1996; 98: 1150.
11. Suciu-Foca N, Liu Z, Colovai AI, et al. Indirect T cell recognition in human allograft rejection. Transplant Proc 1997; 29: 1012.
12. Suciu-Foca N, Reed E, Rubinstein P, Mackenzie W, Ng A, King DW. A late differentiation antigen (LDA1) associated with the helper inducer function of human T lymphocytes. Nature 1985; 318: 465.
13. Liu Z, Harris PE, Colovai AI, Reed EF, Maffei A, Suciu-Foca N. Indirect recognition of donor MHC class II antigens in human transplantation. Clin Immunol & Immunopathol 1996; 78: 228.
14. Zeevi A, Fung J, Zerbe TR, et al. Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation 1986; 41: 620.
15. Renna Molajoni E, Cinti P, Orlandini A, et al. Mechanism of liver allograft rejection: the indirect recognition pathway. Human Immunol 1997; 53: 57.
16. Maino CM, Suni MA, Ruitenberg JJ. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 1995; 20: 127.
17. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305.
18. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mechanisms of allo- recognition: recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphism presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57: 572.
19. Parker KE, Dalchau R, Fowler VJ, Priestley CA, Carter CA, Fabre JW. Stimulation of CD4+ T lymphocytes by allogeneic MHC peptides presented on autologous antigen-presenting cells. Transplantation 1992; 53: 918.
20. Gallon L, Watschinger B, Murphy B, Akalin E, Sayegh MH, Carpenter CB. The indirect pathway of allorecognition. The occurence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation 1995; 59: 612.
21. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 1521.
22. Shirwan H, Learner M, Wang HK, Makowka L, Cramer DV. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Transplantation 1995; 59: 401.
23. Benichou G, Fedoseyeva EV. The contribution of peptides to T cell allorecognition and allograft rejection. Int Rev Immunol 1996; 13: 231.